Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

September 18, 2018

New indication will help Canadians with coronary artery disease prevent heart attack, stroke or death

Rivaroxaban (XARELTO®) 2.5 mg twice daily in combination with acetylsalicylic acid (ASA) 75 mg -100 mg once daily offers a new way to treat Canadians with coronary artery disease Read more
July 17, 2018

Bayer launches Olympus, the premier pre-seed foxtail barley solution for growers across the Prairies

Read more
June 07, 2018

Bayer closes Monsanto acquisition

Read more
June 04, 2018

Bayer plans closing of Monsanto acquisition on June 7

Read more
May 09, 2018

Bayer partners with The Do More Agriculture Foundation to provide mental health resources to Canadian producers

Read more
April 19, 2018

World Malaria Summit 2018:Bayer commits to provide innovative vector control solutions to help eradicate malaria by 2040

Read more
March 21, 2018

European Commission conditionally approves Bayer’s proposed acquisition of Monsanto

Closing of transaction planned for the second quarter of 2018 Read more
December 07, 2017

New Bayer transparency website launched

Enabling access to safety-relevant plant protection study summaries/ Fostering an open and transparent dialog with society/ Support to authorities in dealing with data requests Read more
December 04, 2017

Phase III trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone for patients with metastatic castration-resistant prostate cancer unblinded early

Decision follows a recommendation from an Independent Data Monitoring Committee Read more
November 15, 2017

Heiko Schipper to join Bayer Board of Management and head Consumer Health Division

Erica Mann to leave Bayer effective March 31, 2018 Read more